Menu Search
Equities

Farmacosmo SpA

COSMO:MIL

Farmacosmo SpA

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (EUR)0.49
  • Today's Change-0.009 / -1.80%
  • Shares traded112.48k
  • 1 Year change-25.98%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Farmacosmo SpA had net income fall 61.20% from a loss of 2.00m to a larger loss of 3.23m despite a 8.45% increase in revenues from 65.66m to 71.21m. An increase in the selling, general and administrative costs as a percentage of sales from 3.78% to 6.34% was a component in the falling net income despite rising revenues.
Gross margin6.07%
Net profit margin-4.56%
Operating margin-3.99%
Return on assets-8.98%
Return on equity-19.31%
Return on investment-17.07%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Farmacosmo SpA fell by 1.79m. Cash Flow from Financing totalled 4.74m or 6.66% of revenues. In addition the company used 5.18m for operations while cash used for investing totalled 1.34m.
Cash flow per share-0.0091
Price/Cash flow per share--
Book value per share0.3196
Tangible book value per share-0.0179
More ▼

Balance sheet in EURView more

Farmacosmo SpA has a Debt to Total Capital ratio of 34.22%, a higher figure than the previous year's 9.00%.
Current ratio1.44
Quick ratio0.8409
Total debt/total equity0.5298
Total debt/total capital0.3422
More ▼

Growth rates in EUR

Year on year, growth in earnings per share excluding extraordinary items dropped -56.14%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		34.39
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.